FWWMX
Price
$66.17
Change
-$1.02 (-1.52%)
Updated
Feb 3 closing price
Net Assets
208.21B
PJDCX
Price
$19.21
Change
+$0.42 (+2.24%)
Updated
Feb 3 closing price
Net Assets
78.13M
Interact to see
Advertisement

FWWMX vs PJDCX

Header iconFWWMX vs PJDCX Comparison
Open Charts FWWMX vs PJDCXBanner chart's image
American Funds Washington Mutual 529-F-3
Price$66.17
Change-$1.02 (-1.52%)
VolumeN/A
Net Assets208.21B
PGIM Jennison Rising Dividend C
Price$19.21
Change+$0.42 (+2.24%)
VolumeN/A
Net Assets78.13M
FWWMX vs PJDCX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FWWMX has more cash in the bank: 208B vs. PJDCX (78.1M). FWWMX pays higher dividends than PJDCX: FWWMX (1.45) vs PJDCX (0.11). FWWMX was incepted earlier than PJDCX: FWWMX (5 years) vs PJDCX (12 years). PJDCX (2.18) is less costly to investors than FWWMX (0.31). PJDCX is a more actively managed with annual turnover of: 44.00 vs. FWWMX (29.00). FWWMX has a lower initial minimum investment than PJDCX: FWWMX (250) vs PJDCX (1000). PJDCX annual gain was more profitable for investors over the last year : 9.79 vs. FWWMX (5.50). FWWMX return over 5 years is better than : 40.82 vs. PJDCX (22.14).
FWWMXPJDCXFWWMX / PJDCX
Total Expense Ratio0.311.9916%
Annual Report Gross Expense Ratio0.312.1814%
Fund Existence5 years12 years-
Gain YTD1.5194.57333%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets208B78.1M266,325%
Annual Yield % from dividends1.450.111,279%
Returns for 1 year5.509.7956%
Returns for 3 years30.5226.09117%
Returns for 5 years40.8222.14184%
Returns for 10 yearsN/A97.41-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FHELF0.02N/A
+6.33%
FIRST HELIUM INC
MGDDY19.030.47
+2.53%
CIE GENERALE DES ETABLISSEMENTS MICHELIN SA CLERMONT-FERRAND
BCHHF444.00N/A
N/A
Bucher Holding AG
DMCOF6.76N/A
N/A
d'Amico International Shipping SA
IFTBF5.47N/A
N/A
Infant Bacterial Therapeutics AB